retatrutide phase 2 trial dose escalation schedule Dosage & Titration: Complete Protocol (5-30 mg) Retatrutide Phase 2 NEJM Trial:
Description
"Effects of Triple-Hormone Receptor Agonist Retatrutide on Lipid Profiling in Participants with Obesity." Diabetes
Scientists and drug developers turned this natural hormone into medications called GLP-1 receptor agonists originally to treat type 2 diabetes
I added Tesamorelin at week five
While rapid weight loss causes muscle loss in almost everyone, these populations already face age and hormone-related muscle decline
The medication can cause kidney problems and kidney failure
Not everyone who wants to microdose should
